Precision Biosciences (DTIL) Change in Account Payables (2018 - 2026)
Precision Biosciences (DTIL) reported Change in Account Payables of $648000.0 for Q1 2026, up 711.32% year-over-year from $79869.8 in Q1 2025, and up 161.71% quarter-over-quarter from -$1.0 million in Q4 2025.
Precision Biosciences (DTIL) Change in Account Payables (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Change in Account Payables data on file, last reported at $648000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $648000.0, up 711.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $17000.0 (up 117.0% YoY), and the FY2025 annual result was -$737000.0, up 64.84% from the prior year.
- Change in Account Payables advanced to $648000.0 in Q1 2026 per DTIL's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.0 million in Q4 2023 and troughed at -$2.1 million in Q1 2024.
- A 5-year average of -$30823.5 and a median of $72000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables slumped 1558.33% in 2025, then surged 711.32% in 2026.
- A 5-year view of Change in Account Payables shows it stood at $340000.0 in 2022, then surged by 489.12% to $2.0 million in 2023, then plunged by 96.41% to $72000.0 in 2024, then slumped by 1558.33% to -$1.0 million in 2025, then soared by 161.71% to $648000.0 in 2026.
- Business Quant data shows DTIL's Change in Account Payables at $648000.0 in Q1 2026, -$1.0 million in Q4 2025, and $220000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 648,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 648,000.00 |
| Mar 31, 2026 | 648,000.00 |
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | 220,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | -186,000.00 |
| Sep 30, 2024 | -186,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | -2.10 Mn |
| Mar 31, 2024 | -2.10 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |